ATRBFH: Two-layer Suturing of Achilles Tendon Ruptures

Sponsor
Bispebjerg Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05717270
Collaborator
(none)
23
1
36
0.6

Study Details

Study Description

Brief Summary

The purpose of the present study is to measure whether a new technique of double row suturing of a ruptured Achilles tendon will result in a normalization of the length of the Soleus part (primary outcome) and of the superficial Gastrocnemius part of the tendon (secondary outcome) one-week post-operative. Results will be compared to that of a participants group that underwent the same operation but with a standard operative technique and the same rehabilitation regime recently completed (NCT04263493).

The investigators hypothesize that the new suturing technique will result in an elongation of the Soleus part of the Achilles tendon (primary outcome) by 8.9 mm or less relative to the uninjured contralateral side one week (primary endpoint) after surgery compared to retrospective data from a recently completed randomized controlled trial

Condition or Disease Intervention/Treatment Phase
  • Procedure: Two-layered suture repair

Detailed Description

This study is an ambidirectional cohort study with a retrospective part based on a recently completed trial (NCT04263493) and this prospective registered trial.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
23 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Two-layer Suturing of Achilles Tendon Ruptures - an Ambidirectional Cohort Study
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2025
Anticipated Study Completion Date :
Feb 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Prospective group

Acute Achilles tendon Rupture undergoing surgical repair.

Procedure: Two-layered suture repair
The ruptured Achilles tendon will be sutured in two-layer.

comparison group

Patients group from a previous trial (NCT04263493).

Outcome Measures

Primary Outcome Measures

  1. Tendon length [One week after surgery.]

    The distance between the distal muscle fibers of the Soleus muscle and the posterior most superior part of the calcaneus.

Secondary Outcome Measures

  1. Tendon length Soleus [One week after surgery.]

    The distance (mm) between the distal muscle fibers of the gastrocnemius muscle and the posterior most superior part of the calcaneus.

  2. Tendon length Triceps Surae [6 months.]

    The soleus and gastrocnemius tendon length (mm).

  3. Plantar flexion function [6 and 12 months.]

    Heel-rise test

  4. Patient perception [12 months]

    Achilles Tendon Total Rupture Score (ATRS). The ATRS consist of 10 items, with a total score range from 0 to 100, and a low score indicate more limitations in physical activity and worse symptoms.

  5. Vascularisation [6 months.]

    Doppler flow (area in mm2)

  6. Muscle architecture fascicle length [6 months.]

    Gastrocnemius and soleus muscle fascicle length (mm).

  7. Muscle architecture pennation angle [6 months.]

    Gastrocnemius and soleus muscle pennation angle (°).

  8. Muscle cross sectional area [6 months.]

    Gastrocnemius and soleus tendon and lower limb muscle cross-sectional area (mm2).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with a traumatic, complete mid-substance Achilles tendon rupture

  • Manages transportation to/from the hospital on their own

  • Presented within 14 days from injury

  • Adult (18 to 60 years)

  • Understands Danish

Exclusion Criteria:
  • Other injuries affecting their lower limb functions

  • Prior Achilles contralateral tendon rupture

  • Contraindications for MRI

  • Re-rupture

  • Smoking

  • Systemic diseases influencing tendon healing

  • Anticoagulation treatment

  • Inability to follow rehabilitation or complete follow-ups

  • Immunosuppressive treatment including systemic corticosteroid treatment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute of Sports Medicine Copenhagen Copenhagen NV Denmark 2400

Sponsors and Collaborators

  • Bispebjerg Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anne-Sofie Agergaard, Project administrator, Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT05717270
Other Study ID Numbers:
  • ATR_sutur_BFH
First Posted:
Feb 8, 2023
Last Update Posted:
Feb 8, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2023